Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Hospitals and community health centers urge state protection for 340B access; pharma warns of unintended costs
Summary
A bipartisan group of hospitals and federally qualified health centers told the Senate committee that manufacturer restrictions on contract pharmacies are cutting critical savings; the pharmaceutical industry warned the bill would lock in a broken system that raises employer costs.
The committee heard sharply divergent testimony on Senate Bill 253, which would prohibit pharmaceutical manufacturers from denying 340B pricing to covered entities when drugs are dispensed through contract pharmacies.
What the bill would do: SB 253 would make it an unfair trade practice under state law for a manufacturer to restrict access to 340B drug pricing when a covered entity (hospital, federally qualified health center or Ryan White provider) uses contract pharmacies to dispense medicines to eligible patients.
Sup…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
